| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 50.35 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.11 |
EPS(TTM) : 249.53 |
|
Book Value(₹) : 994.26 |
Market Cap(₹Cr) : 16,120.50 |
Face Value(₹) : 10.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Reserves | 1,263.64 | 975.46 | 822.67 | 768.98 | 692.64 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 1,276.54 | 988.36 | 835.57 | 781.88 | 705.54 |
| Secured Loans | 82.51 | 121.51 | 196.46 | 145.12 | 245.55 |
| Unsecured Loans | 12.88 | 6.94 | 44.07 | 37.18 | 18.19 |
| Total Debt | 95.39 | 128.45 | 240.53 | 182.30 | 263.74 |
| Other Liabilities | 7.13 | 9.83 | 11.45 | 11.96 | 35.30 |
| Total Liabilities | 1,379.06 | 1,126.64 | 1,087.55 | 976.14 | 1,004.58 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1,091.97 | 972.58 | 936.15 | 845.36 | 745.78 |
| Less: Accumulated Depreciation | 268.31 | 215.05 | 168.79 | 129.53 | 93.22 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 823.66 | 757.53 | 767.36 | 715.83 | 652.56 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 45.89 | 40.57 | 20.46 | 17.25 | 23.75 |
| Investments | 1.44 | 0.68 | 4.03 | 7.05 | 8.02 |
| Current Assets, Loans & Advances | |||||
| Inventories | 350.42 | 279.23 | 265.21 | 247.61 | 219.55 |
| Sundry Debtors | 373.53 | 361.77 | 234.33 | 217.73 | 189.89 |
| Cash and Bank Balance | 115.29 | 58.65 | 18.99 | 18.08 | 45.69 |
| Loans and Advances | 80.23 | 60.69 | 57.35 | 58.30 | 51.21 |
| Total Current Assets | 919.47 | 760.34 | 575.87 | 541.73 | 506.34 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 390.89 | 383.50 | 237.57 | 287.75 | 175.93 |
| Provisions | 1.64 | 11.89 | 1.21 | 0.64 | 2.27 |
| Total CL & Provisions | 392.53 | 395.39 | 238.78 | 288.39 | 178.21 |
| Net Current Assets | 526.94 | 364.95 | 337.09 | 253.34 | 328.13 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 12.71 | 13.52 | 16.73 | 10.42 | 19.72 |
| Deferred Tax Liability | 72.05 | 70.82 | 72.51 | 69.42 | 66.68 |
| Net Deferred Tax | -59.34 | -57.30 | -55.78 | -59.00 | -46.96 |
| Other Assets | 40.48 | 20.21 | 14.40 | 41.66 | 39.08 |
| Total Assets | 1,379.07 | 1,126.64 | 1,087.56 | 976.13 | 1,004.59 |
| Contingent Liabilities | 82.56 | 91.21 | 74.68 | 104.71 | 125.34 |